Ivermectin for COVID-19: real-time meta analysis of 102 studies0 0.5 1 1.5+ All studies 61% 102 142,307 Improvement, Studies, Patients Relative Risk Primary outcome 51% 102 142,350 Mortality 49% 51 122,827 Ventilation 29% 19 37,107 ICU admission 35% 14 28,039 Hospitalization 34% 29 44,784 Recovery 39% 38 12,889 Cases 81% 16 13,696 Viral clearance 41% 31 4,217 RCTs 53% 49 16,907 Peer-reviewed 60% 86 128,787 Prophylaxis 85% 17 19,764 Early 61% 39 58,804 Late 39
